Literature DB >> 18340470

Localised Fusobacterium necrophorum infections: a prospective laboratory-based Danish study.

L Hagelskjaer Kristensen1, J Prag.   

Abstract

During a 3-year prospective laboratory-based study in Denmark from 1998 to 2001, all patients who were diagnosed with localised Fusobacterium necrophorum infections were registered with the purpose of describing the variety of localised infections caused by F. necrophorum, especially in the head. We found 267 patients, most of them previously healthy, with localised F. necrophorum infections in the head and neck. In children, F. necrophorum caused otitis media and solitary abscess formation in cervical lymphadenitis. In adolescents, F. necrophorum was found in 21% of peritonsillar abscesses. We also found F. necrophorum in young adults with tonsillitis and in middle-aged adults with sinusitis. F. necrophorum was found in substantial amounts and as the only bacterial pathogen in the majority of patients. All 267 patients recovered without sequelae. We found another 21 localised non-head-and-neck-associated F. necrophorum infections, mainly subcutaneous wound infections in adults. This study shows that F. necrophorum causes a variety of localised infections, especially in the head and neck region, with a characteristic age distribution. We recommend that anaerobic culture is performed on swabs from children with recurrent otitis media and adolescents with non-streptococcal group A tonsillitis.

Entities:  

Mesh:

Year:  2008        PMID: 18340470     DOI: 10.1007/s10096-008-0497-3

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  44 in total

1.  Lemierre's syndrome with spondylitis and pulmonary and gluteal abscesses associated with Mycoplasma pneumoniae pneumonia.

Authors:  M Abele-Horn; P Emmerling; J F Mann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-04       Impact factor: 3.267

2.  Microbiology and management of chronic suppurative otitis media in children.

Authors:  I Brook
Journal:  J Trop Pediatr       Date:  2003-08       Impact factor: 1.165

3.  Lemierre's syndrome: more judicious antibiotic prescribing habits may lead to the clinical reappearance of this often forgotten disease.

Authors:  W Elliot Love; Matthew V Zaccheo
Journal:  Am J Med       Date:  2006-03       Impact factor: 4.965

4.  Variation in tonsil size in 4- to 17-year-old schoolchildren.

Authors:  Ahmet Akcay; Cüneyt Orhan Kara; Erol Dagdeviren; Mehmet Zencir
Journal:  J Otolaryngol       Date:  2006-08

5.  Microbiologic characteristics of persistent otitis media.

Authors:  I Brook; A E Gober
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1998-12

6.  Relationship between clinical signs and symptoms and nasopharyngeal flora in acute otitis media.

Authors:  R Cohen; C Levy; V Hentgen; M Boucherat; F de La Rocque; P d'Athis; E Bingen
Journal:  Clin Microbiol Infect       Date:  2006-07       Impact factor: 8.067

7.  Detection of Fusobacterium necrophorum subsp. funduliforme in tonsillitis in young adults by real-time PCR.

Authors:  A Jensen; L Hagelskjaer Kristensen; J Prag
Journal:  Clin Microbiol Infect       Date:  2007-04-02       Impact factor: 8.067

8.  The epidemiology of peritonsillar abscess disease in Northern Ireland.

Authors:  Brendan C Hanna; Ronan McMullan; Geraldine Gallagher; Sara Hedderwick
Journal:  J Infect       Date:  2005-08-26       Impact factor: 6.072

9.  Microbiology of abscesses of the head and neck in children.

Authors:  I Brook
Journal:  Ann Otol Rhinol Laryngol       Date:  1987 Jul-Aug       Impact factor: 1.547

Review 10.  The management of acute, serous and chronic otitis media: the role of anaerobic bacteria.

Authors:  I Brook; P Burke
Journal:  J Hosp Infect       Date:  1992-11       Impact factor: 3.926

View more
  16 in total

1.  Clinical and biochemical characteristics of patients with Fusobacterium necrophorum-positive acute tonsillitis.

Authors:  Ann Marlene Gram Kjærulff; Marianne Kragh Thomsen; Therese Ovesen; Tejs Ehlers Klug
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-10       Impact factor: 2.503

2.  Significant pathogens in peritonsillar abscesses.

Authors:  T E Klug; J-J Henriksen; K Fuursted; T Ovesen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-12-22       Impact factor: 3.267

3.  Suppurative lymphadenitis.

Authors:  Iain P Fraser
Journal:  Curr Infect Dis Rep       Date:  2009-09       Impact factor: 3.725

4.  Fusobacterial infections in children.

Authors:  Itzhak Brook
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

5.  Neurologic manifestations of Fusobacterium infections in children.

Authors:  Orli Megged; Marc V Assous; Hagit Miskin; Uri Peleg; Yechiel Schlesinger
Journal:  Eur J Pediatr       Date:  2012-09-27       Impact factor: 3.183

6.  Fusobacterium species infections: clinical spectrum and outcomes at a district general hospital.

Authors:  E Pett; K Saeed; M Dryden
Journal:  Infection       Date:  2013-12-11       Impact factor: 3.553

7.  Antibody development to Fusobacterium necrophorum in patients with peritonsillar abscess.

Authors:  T E Klug; J-J Henriksen; M Rusan; K Fuursted; K A Krogfelt; T Ovesen; C Struve
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-09       Impact factor: 3.267

Review 8.  Fusobacterium necrophorum otitis and mastoiditis in infants and young toddlers.

Authors:  T Stergiopoulou; T J Walsh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-03-07       Impact factor: 3.267

9.  A cost-effectiveness analysis of identifying Fusobacterium necrophorum in throat swabs followed by antibiotic treatment to reduce the incidence of Lemierre's syndrome and peritonsillar abscesses.

Authors:  S Bank; K Christensen; L H Kristensen; J Prag
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-11       Impact factor: 3.267

10.  Extensive thoracolumbosacral vertebral osteomyelitis after Lemierre syndrome.

Authors:  D H R Kempen; M van Dijk; A I M Hoepelman; F C Oner; J J Verlaan
Journal:  Eur Spine J       Date:  2014-09-23       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.